NanoediT: Nanoneedle-mediated Genomic Editing for Hypoimmunogenic Regulatory T Cell Manufacturing
Regulatory T cells (Tregs) are immune cells that prevent harmful inflammation. Modified Tregs, equipped with a synthetic receptor called a CAR, are an emerging therapy for autoimmune diseases and transplant rejection. However, current treatments must be made individually for each patient, making them complex, slow, and extremely expensive to produce. A more practical solution is…
